Top Stories
The massive Los Angles fires, stoked by climate change, have been devastating…
BioVaxys Technology Corp. is developing its patented DPX™ platform to address the challenges of lipid nanoparticles (LNPs) in mRNA vaccine delivery. Learn how DPX improves stability, immune responses, and manufacturing economics as the mRNA vaccine market projects $48 billion growth by 2030.
Image source: Getty Images Over the past year or so I’ve…
Image source: Getty Images Airtel Africa (LSE:AAF) isn’t the FTSE 100‘s…
Image source: Getty Images It can be quite daunting when first…
Image source: Getty Images Are defensive shares back on the menu?…
Investments
The CNB’s board will decide the next steps based on the analysis,…
Economy Insights
National News
The Adams administration contradicted a widely held belief that banning parking at corners — aka daylighting — provides better visibility and safety, releasing a report that advocates…
SANTA CLARA, Calif.–(BUSINESS WIRE)–Agilent Technologies Inc. (NYSE: A) will release financial results for the first quarter of fiscal year 2025 after the stock market closes on Wednesday,…
BROOMFIELD, CO – January 24, 2025 (NEWMEDIAWIRE) – Aclarion, Inc., (Aclarion or the Company) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary…
HAMBURG, Germany, Jan. 24, 2025 (GLOBE NEWSWIRE) — In a release issued on January 21, 2025 by XCHG Limited (NASDAQ: XCHG), please note that an incorrect version…
David Owens, the Chief Medical (TASE:) Officer of Nexalin Technology , Inc. (NASDAQ:), has reported the purchase of common stock valued at a total of $7,700. The…
By Andrew Chung (Reuters) – President Donald Trump’s administration asked the U.S. Supreme Court on Friday to put on hold planned arguments in a bid by fuel…